This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Teresa Fletcher
Introduction
Teresa Fletcher is a notable inventor based in Kirkwood, MO (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address inflammatory conditions. Her work exemplifies the intersection of science and innovation, showcasing the potential of targeted therapies.
Latest Patents
Teresa holds a patent for "Benzopyran compounds useful for treating inflammatory conditions." This invention focuses on methods and compounds that are beneficial in treating conditions associated with cyclooxygenase-2 mediated disorders. The compounds of particular interest in her patent are benzopyrans and their analogs, which are defined by a specific formula. This innovative approach has the potential to improve treatment options for patients suffering from inflammatory diseases.
Career Highlights
Teresa Fletcher is associated with Pharmacia Corporation, where she has been able to apply her expertise in medicinal chemistry. Her work at the company has allowed her to contribute to the development of new therapeutic agents. With her dedication and innovative mindset, she has established herself as a valuable asset in her field.
Collaborations
Throughout her career, Teresa has collaborated with notable colleagues, including Jeffry Carter and David Louis Brown. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Teresa Fletcher's contributions to the field of medicinal chemistry through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of inflammatory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
